Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic Stereoidal Injections for Facial Nerve Palsy
NCT03371589Unknown
- Sponsor
- Hillel Yaffe Medical Center
- Start
- Feb 2018
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
01
Overview
Open-label, single-arm trial of dexamethasone in Bell's palsy, sponsored by Hillel Yaffe Medical Center. Primary endpoint: House-Brackmann Facial Nerve Grading System at 6 months. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
Bell's palsy
Beyond the preview
Go deeper on NCT03371589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371589.